Updated:
BVCF Capital
BioVeda China Fund (BVCF) is a life sciences and healthcare investment firm founded in 2005 as China's first US dollar fund focused on that sector.
Overview
BioVeda China Fund (BVCF) is a life sciences and healthcare investment firm founded in 2005 as China's first US dollar fund focused on that sector. It is dedicated to creating and developing innovative global Chinese life sciences companies. BVCF invests across healthcare services, innovative biologics, diagnostics, medical devices, and related areas in China and the U.S., and is managed under international fund governance rules.
General information
Firm type
Private Equity
Year founded
2005
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Principals
Zhi Yang
PhD, Chairman, Founder & Managing Partner
Maggie Chen
Kevin Geng
Vanessa Huang
Valerie Li
Huibing Wang
Yongli Wang
Zongfan Yang
Grace Zhao
Rachel Zhao
Sector focus
Frequently asked questions
What investment stages does BVCF Capital typically target?
The firm lists early-stage seed, start-up, and growth stages.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: